Benzinga is proud to offer conferences and events that provide investors and analysts with in-depth conversations and presentations from publicly traded companies.
While Founder and CEO of Arcimoto (NASDAQ: FUV), Mark Frohnmayer, admits that the 2nd quarter “wasn’t all roses,” there are some who are incredibly bullish on $FUV and all for good reason.
Arcimoto Inc.’s (NASDAQ: FUV) unconventional electric vehicles allow drivers to explore endless possibilities out on the road, and over the past year cruise to handsome profits for investors' portfolios.
Gainers
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 265.5% to close at $15.35 on Tuesday after the company received a written pre-investigational new drug (pre-IND) response from the FDA regarding MMS019.